Literature DB >> 3127871

Tumors of the peripheral nervous system.

I M Ariel1.   

Abstract

Most nerve tumors (benign and malignant) do not arise from the nerves per se, but from the supporting cells; tumors arising from the cells of Schwann are termed schwannoma or neurilemmoma-benign or malignant. Surgical extirpation is the most effective treatment for these tumors. Radiation therapy can offer significant palliation and prolongation of life, but no cures have been observed. Benign tumors can be treated by local surgical extirpation; malignant tumors must be radically resected, including major amputation where indicated. Neurofibromatosis (von Recklinghausen's disease) is a genetic error of metabolism with a proclivity to produce multiple neurofibromas and, in about 10% of the patients, malignant neurilemmomas. Of 100 patients with malignant neurilemmomas treated by the author, 74 were considered determinate; among them, the 10-year "cure" rate was 32%. Patients with von Recklinghausen's disease had almost as good a 10-year survival rate as those with solitary malignant schwannoma (30% vs. 39%).

Entities:  

Mesh:

Year:  1988        PMID: 3127871     DOI: 10.1002/ssu.2980040104

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  7 in total

1.  Primary spinal malignant schwannomas: clinical and prognostic remarks.

Authors:  P Celli; L Cervoni; R Tarantino; A Fortuna
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

2.  Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study.

Authors:  H J Decker; L A Cannizzaro; M J Mendez; S P Leong; H Bixenman; C Berger; A A Sandberg
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

3.  Molecular characterization of a 17q11.2 translocation in a malignant schwannoma cell line.

Authors:  J E Reynolds; J A Fletcher; C H Lytle; L Nie; C C Morton; S R Diehl
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

4.  Selection of internal references for RT-qPCR assays in Neurofibromatosis type 1 (NF1) related Schwann cell lines.

Authors:  Yi-Hui Gu; Xi-Wei Cui; Jie-Yi Ren; Man-Mei Long; Wei Wang; Cheng-Jiang Wei; Rehanguli Aimaier; Yue-Hua Li; Man-Hon Chung; Bin Gu; Qing-Feng Li; Zhi-Chao Wang
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

5.  Treatment and survival differences across tumor sites in malignant peripheral nerve sheath tumors: a SEER database analysis and review of the literature.

Authors:  Enrico Martin; Ivo S Muskens; J H Coert; Timothy R Smith; Marike L D Broekman
Journal:  Neurooncol Pract       Date:  2018-07-19

6.  Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours.

Authors:  D E Porter; V Prasad; L Foster; G F Dall; R Birch; R J Grimer
Journal:  Sarcoma       Date:  2009-04-07

Review 7.  Collagen VI in healthy and diseased nervous system.

Authors:  Ilaria Gregorio; Paola Braghetta; Paolo Bonaldo; Matilde Cescon
Journal:  Dis Model Mech       Date:  2018-05-31       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.